FDA Lifts Clinical Hold on Insmed (INSM) ARIKACE in NTM Patients; Continues CF Negotiations
Go back to FDA Lifts Clinical Hold on Insmed (INSM) ARIKACE in NTM Patients; Continues CF Negotiations| INSMED (NASDAQ: INSM) | Delayed: 109.86 -0.25 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.11 | 52 Week High | $19.30 | |||
| Open | $111.00 | 52 Week Low | $9.02 | |||
| Day High | $111.60 | P/E | N/A | |||
| Day Low | $108.34 | EPS | $-1.69 | |||
| Volume | 1,240,354 | |||||
